US judge blocks Colorado's first-of-its-kind price cap on Amgen drug
A federal judge has blocked Colorado's first-in-the-nation attempt to cap the price of a blockbuster Amgen drug, ruling the company is "likely to be significantly harmed." The Colorado Prescription Drug Affordability Board, established four years ago to tackle rising drug costs, had been the most aggressive of several similar state bodies in setting upper payment limits. The ruling is seen as a victory for the pharmaceutical industry and casts doubt on similar efforts in other states.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!